Fully automated and super-rapid system for the detection of JAK2V617F mutation
Ruriko Tanaka(Kyoto University Hospital), Shinya Kimura(Saga University), Miki Takeuchi(Nagoya University), Junya Kuroda(Kyoto Prefectural University of Medicine), William Stevenson(The University of Sydney), Eri Kawata(Panasonic (Japan)), Yutaka Kobayashi(Gifu University), Satoshi Majima(Arkray (Japan)), Eishi Ashihara(Kyoto Pharmaceutical University), Asumi Yokota(Kyoto University), Tomohiko Taki(Kyorin University), Mitsuharu Hirai(Arkray (Japan)), Yuri Kamitsuji(Panasonic (Japan)), Taira Maekawa(Kyoto University Hospital), Takayuki Ishikawa(Kobe City Medical Center General Hospital), Masafumi Taniwaki(Kyoto Prefectural University), Yoshihide Murotani(Kyoto University Hospital)
Cited by 29
Related Papers
Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes
|Nature Medicine|2020|633
Adenoviral E1A-Associated Protein p300 Is Involved in Acute Myeloid Leukemia With t(11; 22)(q23; q13)
|Blood|1997|262